NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $27.4M
- Insider buysLast 90 days, $77.6K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 30
- 13F valueReported value at the end of Q2 2026
- $2.78M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$55.8M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 184.0K
- Shares sold short
- Change
- −36.9K
- −16.7% vs. previous
- Days to cover
- 2.97
- At average daily volume
Superinvestors holding NXTC, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding NXTC at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by NextCure, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 (view filing)4:19 PM ET | Nov 5-6 | 4 days | Schneeberger Daniel and 1 other10% Owner | PPurchase | +4.69K | $5.10 | +$23.9K | +0.6%738.0K after | 2 lots |
| Oct 27, 2026 (view filing)7:36 PM ET | Oct 23-27 | 4 days | Schneeberger Daniel and 1 other10% Owner | PPurchase | +10.9K | $4.95 | +$53.7K | +1.5%733.3K after | 3 lots |
| Aug 12, 2026 (view filing)11:35 AM ET | Aug 10 | 2 days | Ren Jinsheng and 5 othersOther: Former 10% Owner | SSale | −30.0K | $6.16 | −$184.8K | −8.9%308.6K after | |
| Aug 3, 2026 (view filing)5:53 PM ET | Jul 30-31 | 4 days | Schneeberger Daniel and 1 other10% Owner | PPurchase | +329.2K | $4.93 | +$1.62M | +83.7%722.4K after | 9 lots |
| Jul 29, 2026 (view filing)6:18 PM ET | Jul 27-29 | 2 days | Schneeberger Daniel and 1 other10% Owner | PPurchase | +17.6K | $4.98 | +$87.7K | +4.7%393.3K after | 4 lots |
Top 10 13F holders, Q2 2026
See all 30 holdersThe largest institutional positions in NextCure, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 288,303 | $461.3K | 0.08% | +50,000+21.0% | Added |
| Adage Capital Partners GP, L.L.C. | 277,202 | $443.5K | 0.00% | +277,202 | New |
| Sofinnova Investments, Inc. | 222,654 | $356.2K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 171,202 | $273.9K | 0.00% | +110,668+182.8% | Added |
| Vanguard Capital Management LLC | 156,842 | $250.9K | 0.00% | −3,631−2.3% | Reduced |
| Millennium Management LLC | 88,112 | $141.0K | 0.00% | +88,112 | New |
| Boothbay Fund Management, LLC | 84,687 | $135.5K | 0.00% | +15,070+21.6% | Added |
| Squadron Capital Management LLC | 64,464 | $103.1K | 0.04% | −200,536−75.7% | Reduced |
| Verdad Advisers, LP | 60,451 | $96.7K | 0.09% | +17,496+40.7% | Added |
| Pfizer Inc | 44,347 | $73.0K | 0.04% | −109,007−71.1% | Reduced |
Holders of 5% or more of NXTC
See all 7 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of NextCure, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 13G | 15.80%722.4K shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Ikarian Capital, LLC | 13G/A | 9.99%502.7K shares | 0.00 ppfrom 9.99% | Feb 17, 20262 filings | Aug 14, 2026 | SEC |
| JP Sailing Capital Ltd | 13G | 9.90%455.0K shares | New | Oct 20, 20261 filing | Oct 20, 2026 | SEC |
| Simcere Zaiming, Inc. | 13G/A | 9.40%338.6K shares | −3.30 ppfrom 12.70% | Aug 19, 20252 filings | May 6, 2026 | SEC |
| Adage Capital Management, L.P. | 13G | 7.67%277.2K shares | New | Aug 12, 20261 filing | Aug 12, 2026 | SEC |